iRhythm Technologies (NASDAQ:IRTC) vs. Organigram Global (NASDAQ:OGI) Head-To-Head Comparison

Organigram Global (NASDAQ:OGI) and iRhythm Technologies (NASDAQ:IRTC) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, valuation and earnings.

Risk & Volatility

Organigram Global has a beta of 1.55, indicating that its stock price is 55% more volatile than the S&P 500. Comparatively, iRhythm Technologies has a beta of 1.39, indicating that its stock price is 39% more volatile than the S&P 500.

Valuation and Earnings

This table compares Organigram Global and iRhythm Technologies”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Organigram Global	$185.07 million	0.65	-$17.70 million	$0.46	1.86
iRhythm Technologies	$747.14 million	3.99	-$44.55 million	($1.17)	-75.79

Organigram Global has higher earnings, but lower revenue than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Organigram Global and iRhythm Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Organigram Global	28.14%	-13.39%	-8.67%
iRhythm Technologies	-4.52%	26.88%	4.32%

Institutional and Insider Ownership

34.6% of Organigram Global shares are owned by institutional investors. 0.1% of Organigram Global shares are owned by company insiders. Comparatively, 1.0% of iRhythm Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current ratings and target prices for Organigram Global and iRhythm Technologies, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Organigram Global	0	1	2	0	2.67
iRhythm Technologies	1	2	13	1	2.82

iRhythm Technologies has a consensus price target of $164.07, indicating a potential upside of 85.02%. Given iRhythm Technologies’ stronger consensus rating and higher possible upside, analysts plainly believe iRhythm Technologies is more favorable than Organigram Global.

Summary

iRhythm Technologies beats Organigram Global on 9 of the 14 factors compared between the two stocks.

About Organigram Global

Organigram Global Inc. is a Canadian cannabis company that develops, produces and sells cannabis products for adult-use recreational and medical markets. The company offers dried flower, pre-rolls, cannabis beverages, vapes, edibles and concentrates under a portfolio of brands that has included Edison, SHRED, Big Bag O’ Buds, Trailblazer, Monjour and Laurentian. Organigram operates in Canada through cultivation, processing and manufacturing facilities, including its main production operations in Moncton, New Brunswick.

About iRhythm Technologies

iRhythm Technologies is a medical technology company that develops digital solutions for detecting and monitoring heart rhythm disorders. Its services combine wearable electrocardiogram (ECG) devices with cloud-based data analysis and clinical reporting to help healthcare professionals assess patients for conditions such as cardiac arrhythmias. The company’s Zio product line includes wearable ECG monitors, such as Zio XT, which records a patient’s heart activity during an extended monitoring period. iRhythm also offers Zio AT, a monitoring service designed to provide clinicians with ECG data during the monitoring period.